the high yield expansion and megakaryocytic differentiation of human umbilical cord blood cd133+ cells
Authors
abstract
objective: despite of many benefits, umbilical cord blood (ucb) hematopoietic stem cell (hsc) transplantation is associated with low number of stem cells and slow engraftment; in particular of platelets. so, expanded hscs and co-transfusion of megakaryocyte (mk) progenitor cells can shorten this period. in this study, we evaluated the cytokine conditions for maximum expansion and mk differentiation of cd133+ hscs. materials and methods: in this experimental study, the cd133+ cells were separated from three cord blood samples by magnetic activated cell sorting (macs) method, expanded in different cytokine combinations for a week and differentiated in thrombopoietin (tpo) for the second week. differentiation was followed by the flow cytometry detection of cd41 and cd61 surface markers. colony forming unit (cfu) assay and dna analysis were done for colonogenic capacity and ploidy assay. results: cd133+ cells showed maximum expansion in the stem span medium with stem cell factor (scf) + fms-like tyrosine kinase 3-ligand (flt3-l) + tpo but the maximum differentiation was seen when cd133+ cells were expanded in stem span medium with scf + interleukin 3 (il-3) + tpo for the first and in tpo for the second week. colony forming unit-mk (cfu-mk) was formed in three sizes of colonies in the mega-cult medium. in the dna analysis; 25.2 ± 6.7% of the cells had more than 2n dna mass. conclusion: distinct differences in the mk progenitor cell count were observed when the cells were cultured in stem span medium with tpo, scf, il-3 and then the tpo in the second week. such strategy could be applied for optimization of cd133+ cells expansion followed by mk differentiation.
similar resources
The High Yield Expansion and Megakaryocytic Differentiation of Human Umbilical Cord Blood CD133+ Cells
OBJECTIVE Despite of many benefits, umbilical cord blood (UCB) hematopoietic stem cell (HSC) transplantation is associated with low number of stem cells and slow engraftment; in particular of platelets. So, expanded HSCs and co-transfusion of megakaryocyte (MK) progenitor cells can shorten this period. In this study, we evaluated the cytokine conditions for maximum expansion and MK differentiat...
full textNanofiber Expansion of Umbilical Cord Blood Hematopoietic Stem Cells
Background The aim of this study was the ex vivo expansion of Umbilical Cord Blood hematopoietic stem cells on biocompatible nanofiber scaffolds. Materials and Methods CD133+ hematopoietic stem cells were separated from umbilical cord blood using MidiMacs (positive selection) system by means of monocolonal antibody CD133 (microbeads) subsequently, flowcytometry method was done to asses...
full textexpansion of cd133(+) umbilical cord blood derived hematopoietic stem cells on a biocompatible microwells.
umbilical cord blood (ucb) as a source of hematopoietic stem/progenitor cells (hspcs) used for umbilical cord blood transplantation (ucbt). the main obstacle in application of this source as an appropriate source of hspcs is low volume of this product. so ex vivo expansion of these cells in a microenvironment which mimic body condition is important. in current study we designed biocompatible mi...
full textEffects of CXCR1 and CXCR2 inhibition on expansion and differentiation of umbilical cord blood CD133(+) cells into megakaryocyte progenitor cells.
OBJECTIVE There have been various reports on the roles of CXC receptors (CXCR) in modulation of hematopoiesis. In the present study, we investigated the effects of CXCR1 and/or CXCR2 inhibition on expansion and differentiation of umbilical cord blood (UCB) CD133(+) cells into megakaryocytic progenitors. MATERIALS AND METHODS Purified UCB CD133(+) cells were cultured in a serum-free liquid cul...
full textcharacterization of megakaryocyte progenitor cells differentiated from umbilical cord blood cd133+ and cd133– cells
objective: this study was performed to determine the immunophenotype of megakaryocyte progenitor cells differentiated from ucb cd133+ and cd133− cells under the effects of interleukin–3 (il–3), interleukin–6 (il–6), stem cell factor (scf) and thrombopoietin (tpo) in vitro. materials and methods: cd133+and cd133− cells were isolated by using cd133 isolation kit following the manufacturer’s instr...
full textIn-vitro Differentiation of Human Umbilical Cord Wharton’s Jelly Mesenchymal Stem Cells to Insulin-Producing Cells
Background & Objective: Diabetes is a major chronic metabolic disease in the world. Islet transplantation is a way to treat diabetes. Unfortunately, this method is restricted due to graft rejection and lack of donor islets. Mesenchymal Stem Cells (MSCS) have the ability to differentiate into Insulin-Producing Cells (IPCs). In this study, Human Umbilical Mesenchymal Stem Cells (HUMSCS) were in...
full textMy Resources
Save resource for easier access later
Journal title:
cell journalجلد ۱۳، شماره ۳، صفحات ۱۷۳-۱۷۸
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023